Digital Library
Close Browse articles from a journal
 
Search for with title:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             140 results found
no title author magazine year volume issue page(s) type
1 Abstract withdrawn
1 S1 p. 31
 article
2 Abstract withdrawn
1 S1 p. 11
 article
3 Administration of panobinostat is associated with increased IL-17A mRNA in the intestinal epithelium of HIV-1 patients Christensen, A. Bjerg
1 S1 p. 35
 article
4 Allogeneic stem cell transplantation in HIV-1 infected individuals Wensing, A.M.J.
1 S1 p. 23-24
 article
5 Antiretroviral drug activity in macaque PrEP breakthrough infections has only a transient effect on cell-associated SHIV DNA reservoirs García-Lerma, J.G.
1 S1 p. 6
 article
6 Antiviral therapy by targeting nanoparticles to CD4+ cells for the delivery of SIV-specific RNA-guided Cas9 nucleases Giavedoni, L.
1 S1 p. 15
 article
7 A pharmacologic basis for HIV persistence Fletcher, C.
1 S1 p. 10
 article
8 Approaches to discover latency-reversing agents
1 S1 p. 11
 article
9 A subset of infectious proviruses persist and expand following activation ex vivo Bui, J.K.
1 S1 p. 10-11
 article
10 Asymptomatic cerebrospinal fluid viral escape during ART is associated with increased intrathecal immune activation Eden, A.
1 S1 p. 33
 article
11 A theoretical framework to guide clinical trial design to estimate efficacies of latency-reversing agents Ke, R.
1 S1 p. 29
 article
12 Author index
1 S1 p. 43-45
 article
13 CCR5- and CXCR4-tropic HIVs infect CD4+ hematopoietic stem and progenitor cells in vitro and in optimally treated people Sebastian, N.
1 S1 p. 33-34
 article
14 CD8+ sensing relies on nanomolar levels of antigen presented upon HIV-1 reactivation Ruiz, A.
1 S1 p. 9
 article
15 Cell-associated HIV-1 DNA and viral load evaluation in HIV-1 infected children before and after combination antiretroviral therapy initiation Moragas, M.
1 S1 p. 27
 article
16 Cellular HIV RNA/DNA as biomarkers of inducible virion production Cillo, A.
1 S1 p. 3
 article
17 Challenges in designing clinical trials in cure research Eron, J.
1 S1 p. 12
 article
18 Characterization of humanized NSG mice to evaluate latency Satheesan, S.
1 S1 p. 19
 article
19 CL572, a potent agonist of Toll-like receptor 2/7, as a novel latency-reversing agent Macedo, A.
1 S1 p. 14
 article
20 Clones of SIV-infected cells are present in spleen and lymph nodes in rhesus macaques Hughes, S.H.
1 S1 p. 1
 article
21 Co-culture of T-cells with dendritic cells facilitates HIV latency in proliferating CD4+ T-cells: implications for the establishment and reversal of latency Kumar, N.
1 S1 p. 20
 article
22 Co-expression of multiple inhibitory receptors on CD8+ T cells in viremic and ART-suppressed HIV-1(+) individuals Macatangay, B.
1 S1 p. 36
 article
23 Computational detection of off-target effects of CRISPR/Cas9-associated gRNAs Dampier, W.
1 S1 p. 39-40
 article
24 Constraints on the dynamics of HIV-1 lifecycle elucidated by treatment with an integrase inhibitor reveal a subset of cells with very slow integration Ribeiro, R.M.
1 S1 p. 23
 article
25 Correlation between HIV-2 RNA and HIV-2 total DNA levels Charpentier, C.
1 S1 p. 28-29
 article
26 Cyanotriazoles activate latent HIV and strongly synergize with proteasome inhibitors ex vivo in resting CD4 T cells from suppressed HIV+ donors Murry, J.
1 S1 p. 12
 article
27 Dendritic cell induced “kick” of latent HIV-1 in vitro during cART Mailliard, R.B.
1 S1 p. 17
 article
28 Detection and enrichment to near purity of rare HIV-1 infected cells by PrimeFlow RNA Romerio, F.
1 S1 p. 5
 article
29 Detection of replication competent HIV from latently infected CD4+ T cells Fun, A.
1 S1 p. 26
 article
30 Developing and applying ultrasensitive p24 protein immunoassay for HIV latency Howell, B.J.
1 S1 p. 5
 article
31 Differential effects of HIV latency-reversing agents on T cell phenotype and function: implications for HIV cure Clutton, G.
1 S1 p. 8-9
 article
32 Differential efficacy of antiretroviral drugs in HIV-1 infected human microglia Asahchop, E.L.
1 S1 p. 37
 article
33 Diverse proviral structure of HIV integrants in clonally expanded cells Simonetti, F.R.
1 S1 p. 31
 article
34 Diversity changes in blood HIV-1 DNA reservoir after combination of chemotherapy and autologous hematopoietic stem cell transplantation for lymphoma Delagreverie, H.
1 S1 p. 30
 article
35 Donor-to-donor variation in the host gene expression response to SAHA Moesker, B.
1 S1 p. 37
 article
36 Dual-affinity re-targeting (DART) proteins overcome viral diversity to deplete the latent HIV-1 reservoir Sung, J.M.
1 S1 p. 18
 article
37 Duplex droplet digital PCR to study the composition of HIV-DNA in blood cells Simonetti, F.R.
1 S1 p. 30
 article
38 Effects of heme degradation products on reactivation of latent HIV-1 Melkova, Z.
1 S1 p. 42
 article
39 Elimination of HIV-1 genomes from human T-lymphoid cells by CRISPR/Cas9 gene editing Khalili, K.
1 S1 p. 16
 article
40 Emergence of treatment-resistant infectious HIV after genome-directed antiviral endonuclease therapy Jerome, K.R.
1 S1 p. 16
 article
41 Emerging results of an extensive survey of potential participants’ willingness to take risks in and donate to HIV cure research in the United States Taylor, J.
1 S1 p. 13
 article
42 Estrogen potently blocks HIV re-emergence from latency and points to gender-specific differences in HIV reservoirs and novel cure strategies Karn, J.
1 S1 p. 20-21
 article
43 Evaluation of HIV latency reversal using designed PKC modulators in humanized BLT mice Marsden, M.D.
1 S1 p. 1
 article
44 Evidence of ongoing HIV replication during suppressive antiretroviral therapy Giron, L. Bertoni
1 S1 p. 29-30
 article
45 Exosomes from HIV-1 infected cells stimulate production of pro-inflammatory cytokines through TAR RNA. Sampey, G.C.
1 S1 p. 22
 article
46 Ex vivo determination of stem cell transplantation graft-versus-HIV reservoir effects Hogan, L.E.
1 S1 p. 19
 article
47 Gene editing CCR5 in HIV subjects CD4 T cells Ando, D.
1 S1 p. 11-12
 article
48 Genetic and functional characterization of HIV-1 Nef gene from North Indian HIV-1 infected patients Singh, J.
1 S1 p. 24
 article
49 Genetic variation continues to occur in well-controlled HIV-1-infected patients Dampier, W.
1 S1 p. 42
 article
50 Hematopoietic stem and progenitor cells harbor provirus with identical Gag and V3 sequences as residual plasma virus in optimally treated patients Terry, V.H.
1 S1 p. 34
 article
51 HIV alters the profile of cytokines responding to seasonal influenza vaccination González, L.
1 S1 p. 35
 article
52 HIV antibodies as markers of HIV systemic reservoir and replication activity Keating, S.M.
1 S1 p. 28
 article
53 HIV conserved region vaccine in early cART-treated subjects (BCN01): impact on immunogenicity and the latent reservoir Morón-López, S.
1 S1 p. 14-15
 article
54 HIV isolated from CSF cells of a virologically controlled patient infects astrocytes Li, G.H.
1 S1 p. 33
 article
55 HIV-1 latency is established preferentially in minimally activated and non-dividing cells during productive infection of primary CD4 T cells Spina, C.A.
1 S1 p. 4-5
 article
56 HIV-1 mediated insertional activation of STAT5B promotes the formation of a viral reservoir in T regulatory cells Cesana, D.
1 S1 p. 31
 article
57 HIV persistence: to the periphery and beyond Martinez, J.V. Garcia
1 S1 p. 1
 article
58 HIV-1 silencing mediated by TRIM22 inhibition of Sp1 binding to the promoter Vicenzi, E.
1 S1 p. 21
 article
59 HIV-1 transcriptional latency in resting CD4 T-cell Benkirane, M.
1 S1 p. 3
 article
60 Human galectin-9 is a potent mediator of HIV transcription and reactivation Abdel-Mohsen, M.
1 S1 p. 18
 article
61 Immune activation in successfully treated patients with HIV-associated neurocognitive disorders: difference according to the severity of the impairment Vassallo, M.
1 S1 p. 32-33
 article
62 Immune activation profile associated with comorbidities in successfully treated HIV infected patients Psomas, C.
1 S1 p. 36-37
 article
63 Immune control of HIV reservoirs and cure therapeutic strategies Autran, B.
1 S1 p. 8
 article
64 Immune response to sequences surrounding the 12 protease cleavage sites generated during ARV treatment improved CD4 counts of SIVmac251 infected rhesus monkeys Luo, M.
1 S1 p. 15-16
 article
65 Immunological properties of testicular tissue as an anatomical reservoir in ART-treated HIV-infected adults Routy, J.P.
1 S1 p. 7-8
 article
66 Impact of a decade of sustained antiretroviral therapy started during HIV-1 seroconversion on blood and gut reservoirs Kinloch, S.
1 S1 p. 25
 article
67 Impairment of the long-term ability of dolutegravir-resistant viruses to integrate Wainberg, M.A.
1 S1 p. 40-41
 article
68 Induction of HIV from latency by a novel molecule Archin, N.M.
1 S1 p. 41
 article
69 Ingenol derivatives are potent reactivators of latent HIV Planelles, V.
1 S1 p. 22
 article
70 Integrated and total HIV-1 DNA can predict quantitative viral outgrowth in patients on long-term ART De Spiegelaere, W.
1 S1 p. 29
 article
71 Integrated HIV DNA accumulates more rapidly in non-controllers than controllers Pinzone, M.R.
1 S1 p. 25-26
 article
72 Integration site analysis of latently infected cell lines: evidence of ongoing replication Symons, J.
1 S1 p. 4
 article
73 In vitro analysis of different PKC agonists: latency reversal, T-cell activation, cytokine production and isoform selectivity Barnard, R.
1 S1 p. 38
 article
74 In vivo expression of unspliced HIV RNA in expanded CD4+T-cell clones containing defective or replication-competent proviruses Kearney, M.F.
1 S1 p. 6
 article
75 In vivo suppression of SIV-mediated immune activation by a p38 MAPK inhibitor combined with ART Aldovini, A.
1 S1 p. 2
 article
76 Kinetics of HIV production by monocyte derived macrophages (MDM) in the presence of erythrocytes Fazzi, L.
1 S1 p. 32
 article
77 Latency-reversing agents and cellular activation affect antigen processing in primary CD4 T cells Boucau, J.
1 S1 p. 10
 article
78 LEDGF/p75 and Iws1 participate both cooperatively and independently to distinct steps of HIV transcription Emiliani, S.
1 S1 p. 22-23
 article
79 Levels of SAMHD1 and natural ribonucleotides may alter anti-HIV potency of antiretroviral agents in primary CD4+ CCR5+ placental macrophages Gavegnano, C.
1 S1 p. 32
 article
80 Limitations of employing antibody drug conjugates (ADCs) for targeting HIV infected cells as a strategy for hiv cure Strizki, J.
1 S1 p. 39
 article
81 Long-lived Th17 subsets contribute to HIV-1 persistence under ART Ancuta, P.
1 S1 p. 9
 article
82 Long-term spontaneous control of HIV-1 relates to low frequency of infected cells and inefficient viral reactivation Prado, J.G.
1 S1 p. 8
 article
83 Low viral reservoir treated patients (LoViReT): clinical predictors of low HIV-1 DNA Salgado, M.
1 S1 p. 26-27
 article
84 Lymphatic and cancer tissues are a potential reservoir of replicating virus in virally suppressed ART+ patients Rose, R.
1 S1 p. 7
 article
85 Lymphoid tissue and blood CD4 T cells respond differently to latency-reversing agents: are we testing the right cells? Gramatica, A.
1 S1 p. 11
 article
86 Memory CD4+ T cell subsets show differential responses to HIV latency-reversing agents Kulpa, D.A.
1 S1 p. 2
 article
87 Mild cognitive impairment in a clinically latent HIV-1 patient population Devlin, K.N.
1 S1 p. 24
 article
88 Mixed effects of HDACi on host gene expression and their implications for HIV reactivation from latency Beliakova-Bethell, N.
1 S1 p. 4
 article
89 Modulations in key defense responses of epithelial cells during co-stimulation with BCG and HIV-Nef Mehto, S.
1 S1 p. 34
 article
90 Molecular profiling of antigen-specific peripheral T follicular helper cells from HIV-infected donors using influenza vaccination model de Armas, L.
1 S1 p. 35-36
 article
91 Most tissues of a plasma-negative HIV autopsy cohort contain HIV DNA and many exhibit tissue pathology Rose, R.
1 S1 p. 34
 article
92 Multi-dose romidepsin in SIV-infected rhesus macaques (RMs) reactivates latent, replication-competent virus in the absence of antiretroviral therapy (ART) Policicchio, B.
1 S1 p. 38-39
 article
93 Neutraplex nanoparticles to target HIV reservoirs Lavigne, C.
1 S1 p. 41
 article
94 NNRTIs reduce HIV-1 production from latently infected resting CD4+ T cells Zerbato, J.
1 S1 p. 19
 article
95 No selection of CXCR4-using variants in cell reservoirs of dual-mixed HIV infected patients receiving suppressive maraviroc therapy Izopet, J.
1 S1 p. 31-32
 article
96 Novel CD4-based bi-specific chimeric antigen receptors: toward a functional cure of HIV infection Bolivar-Wagers, S.
1 S1 p. 40
 article
97 Pathogenicity of CD16+ monocyte-derived dendritic cells during HIV-1 infection Wacleche, V.S.
1 S1 p. 36
 article
98 Peripheral blood CD4+ T cells and intestinal lamina propria mononuclear cells contribute to viremia following an analytical treatment interruption: a follow-up analysis of the panobinostat trial Barton, K.
1 S1 p. 30
 article
99 Peripheral blood lymphocytes from patients with chronic myeloid leukemia on treatment with dasatinib are resistant to HIV-1 infection Coiras, M.
1 S1 p. 17
 article
100 Persistence of HIV-infected alveolar macrophages after suppressive ART Hong, F.F.
1 S1 p. 8
 article
101 Population genetic approaches to estimating the size of the HIV reservoir Hattori, J.
1 S1 p. 27
 article
102 Post-mortem analysis of HIV-1 reservoir after allogeneic transplantation using stem cells Nijhuis, M.
1 S1 p. 27-28
 article
103 Potent CTL responses to conserved element of HIV to improve therapeutic DNA vaccine efficacy Felber, B.K.
1 S1 p. 15
 article
104 Potential role for neutralizing antibodies in HIV-1 infection Mascola, J.
1 S1 p. 14
 article
105 Predicting determinants of long-term HIV control with gene therapy strategies Hill, A.L.
1 S1 p. 41
 article
106 Proliferation of perivascular macrophages in macaque models of lentiviral encephalitis: a potential mechanism for HIV/SIV persistence in the brain Kim, W.K.
1 S1 p. 6-7
 article
107 Quantifying the impact of autologous transplantation on viral reservoirs in a nonhuman primate model of HIV/AIDS Peterson, C.W.
1 S1 p. 2-3
 article
108 Reactivation of VOA-inducible and -uninducible HIV-1 proviruses using immune-compromised mice engrafted with human resting CD4+ T cells Yuan, Z.
1 S1 p. 20
 article
109 Real-time predictions of reservoir size and rebound time during antiretroviral therapy interruption trials for HIV Hill, A.L.
1 S1 p. 13
 article
110 Restricted HIV-1 diversity and clonal expansion following cytoreductive chemotherapy Henrich, T.J.
1 S1 p. 17-18
 article
111 Role of drug transporters and metabolic enzymes in antiretroviral drug (ARV) disposition in testicular tissue: potential contribution to HIV-1 persistence Bendayan, R.
1 S1 p. 11
 article
112 Sequential treatment with 5-aza-2′deoxycitidine and deacetylase inhibitors reactivates HIV Van Lint, C.
1 S1 p. 39
 article
113 Shining the RNA-Seq microscope on models of HIV latency Woelk, C.H.
1 S1 p. 1-2
 article
114 Significance of a novel residual HIV-1 variant longitudinally detected in plasma of a patient on suppressive antiretroviral therapy Sahu, G.K.
1 S1 p. 25
 article
115 Single-cell analysis identifies biomarkers for HIV permissiveness Ciuffi, A.
1 S1 p. 3
 article
116 SNPs within the HIV-1 LTR associate with increased virus persistence Sullivan, N.T.
1 S1 p. 26
 article
117 Strategies to overcome active and latent HIV: attack is the best way for defense Shadad, H.
1 S1 p. 40
 article
118 Suppression of the HIV-1 reservoir with a potent Tat inhibitor Valente, S.
1 S1 p. 38
 article
119 Sustained HIV release by single persisting CD4+ T cells during latency disruption Hataye, J.M.
1 S1 p. 5-6
 article
120 Targeting HIV reservoir by DART molecules that recruit T cells to HIV Env expressing cells: comparison of HIV arms derived from broadly reactive neutralizing or non-neutralizing anti-Env antibodies Nordstrom, J.L.
1 S1 p. 14
 article
121 The anti-inflammatory response and the HIV cure Sekaly, R.
1 S1 p. 16
 article
122 The effects of combination of ingenol-B and ART to SIV251 infected rhesus monkeys dos Santos Goncalves, G.
1 S1 p. 16-17
 article
123 The HIV-1 antisense transcript AST is an inducer of viral latency Romerio, F.
1 S1 p. 3-4
 article
124 The human lung is a site of productive HIV infection during long-term ART: novel tools to study ART-durable HIV reservoirs Gludish, D.W.
1 S1 p. 7
 article
125 The importance of GPP implementation in HIV cure research: learning from prevention Handibode, J.
1 S1 p. 13
 article
126 The steroid receptor coactivators are targets for reactivation of HIV latency Nikolai, B.C.
1 S1 p. 23
 article
127 The synergistic effect of PKA activator and HDAC inhibitor to reactivate HIV-1 provirus from latently infected cells Choi, B.S.
1 S1 p. 24
 article
128 The transcriptional program governed by RORγt favors HIV-1 replication in CCR4+CCR6+ Th17 cells Wacleche, V.S.
1 S1 p. 10
 article
129 The unique enrichment of histone modifications and its relationship with HIV-1 latency in some chromosomes Kim, K.C.
1 S1 p. 21-22
 article
130 The utility of the Connectivity Map (CMAP) for HIV cure strategies Gunawardana, Y.P.
1 S1 p. 37-38
 article
131 The virology of HIV-1 persistence: integration, expansion, and expression Coffin, J.
1 S1 p. 5
 article
132 Tissue localization of human T cell responses Farber, D.
1 S1 p. 6
 article
133 Towards achieving a state of reversible HIV-1 latency in primary monocyte-derived macrophages (MDM) by M1 polarization Poli, G.
1 S1 p. 20
 article
134 Towards HIV reservoir measurements in ART-treated patients: integrated DNA quantification and HIV-1 clone expansion in a Japanese cohort Stanoeva, K.
1 S1 p. 25
 article
135 Triazol-1-ol analogues as novel therapeutic leads towards reactivating and eradicating latent HIV-1 by manipulating SUMOylation of STAT5 Bosque, A.
1 S1 p. 12
 article
136 Ultradeep sequencing characterization of HIV-1 diversity in primary infection Delaugerre, C.
1 S1 p. 28
 article
137 Uncovering mechanisms of HIV persistence in HIV controllers by HIV sequence analysis in CD4 T cell subsets Boritz, E.
1 S1 p. 9-10
 article
138 Utilizing the binding capacity of CRISPR/Cas9 to target the HIV-1 quasispecies Nonnemacher, M.
1 S1 p. 42
 article
139 Viral counteractions against CTIP2 in HIV-1 permissive cells Forouzanfar, F.
1 S1 p. 21
 article
140 Virologic and immunologic correlates of viral control after ART-interruption in SIV-infected rhesus macaques Paiardini, M.
1 S1 p. 35
 article
                             140 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands